The authors developed mouse models of CRC with metastatic recurrence following primary tumor surgery, discovering that HRCs remained “hidden” after primary tumor excision, giving rise to various cell types, including LGR5+ stem-like cells, and causing overt metastatic disease. This evidence concerns the gene LGR5 and colorectal carcinoma.